ARCTCIK 1768224

Arcturus Therapeutics Holdings Inc.

EDGAR filings

Customers

1 active

Suppliers

None disclosed

Largest customer

80%

CSLLY · FY to 2025-12-31

Named-customer revenue

$65.6M

1 customer · FY to 2025-12-31

Latest period

Dec 31, 2025

10-K filed 2026-03-03

Band height is the estimated dollar value: the disclosed share × the discloser's revenue for that period (latest full year where available). Thin bands are named without a figure. Click a band to open its filing.

Customers 1

Companies ARCT discloses as major customers, as a share of ARCT revenue. 1 active, 0 lapsed.

Company	% of ARCT revenue	Est. revenue	Period	Trend	Status	Source
CSLLY CSL LTD	80%	$65.6M	FY 2025-12-31	−11.0pp	Active	10-K 2026-03-03
For the year ended December 31, 2025: •CSL – 80% of total revenue •BARDA – 16% of total revenueFor the year ended December 31, 2024: •CSL – 91% of total revenue For the year ended December 31, 2023: •CSL – 92% of total revenue Given this concentration, the Company’s financial performance and cash flows may be materially impacted if there are changes in demand, contract renewals, or the financial condition of these key customers. 10-K filed 2026-03-03 Period FY 2025-01-01 to 2025-12-31 (80%), FY 2024-01-01 to 2024-12-31 (91%), FY 2023-01-01 to 2023-12-31 (92%)Accession 0001193125-26-088391

Alerts are coming

Get an email when ARCT's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.